News Room
Latest at MEND
1st September, 2010
MEND selected as a Technology Pioneer by the World Economic Forum
MEND has been selected by the World Economic Forum as one of the 31 Technology Pioneers for 2011. The forum awareded visionary technology early stage company from around the world who are poised to have highly postive impact on the futur of health, business, industry and society. Read more. or View Video
9 March, 2010
Best Entreprise Award 2010
MEND SA was the recipient of the "Best Entreprise Award" for the small/medium entreprise cathegory in South African Quality Awards for 2009/2010, hosted by the Department of Trade and Industry (DTI), South African National Accreditation System (SANAS), South African Buro of Standarts (SABS) and National Metrology Insitute of South Africa (NMISA).
5 February, 2010
Medicine in Need receives $3 million grant from the Bill and Melinda Gates Foundation to apply adavanced formulation technologies to the stabilization of a new malaria vaccine candidates.
Read more.
10, 11 and 12 March, 2009
2nd consortium meeting
MEND Innovation & Translation Alliance organizes at Le Laboratoire in Paris a conference where pharmaceutical scientists, engineers, and others, from industry and academia, meet to generate innovation on the development and implementation of advanced delivery technology.
20 – 22 October, 2008
Grand Challenges in Global health in Bangkok
In 2003 at the world economic forum, Bill Gates announced the Grand Challenges in Golbal Health awarding $200-milion medical research initiative. Few years later 14 challenges were identified and several projects awarded: MEND’s research on Needle Free Vaccination Via Nanoparticle Aerosols is one of them. MEND is part of the Bangkok meeting and the James Nachtwey exhibit on Tuberculosis it supported will be presented. Read more.
6 November, 2007
Medicine in Need receives $8.3 million grant from Gates Foundation to apply advanced biomaterial science to three major vaccine and drug challenges in global health today.
Read more.
In the News
15 April, 2010, Science Daily
Aerosols: New Tool Against Tuberculosis?
Scientists have developed a new strategy for treating tuberculosis using dry powder aerosols that could be delivered with an inhaler. Read more.
16 October, 2008, Xconomy, Boston
First inhalable Tuberculosis vaccine being prepped for clinical trials by Harvard, MEND Scientists.
David Edwards, a biomedical engineering professor at Harvard University, thinks he may have a better vaccine against tuberculosis in the works. He’s negotiating with the Bill & Melinda Gates Foundation and other international nonprofits to pump enough cash into a clinical trial to get an early glimpse into whether he’s really onto something. Read more.
6 October, 2008
Nobel Prize 2008 in Medicine awarded to Professors Françoise Barré-Sinoussi and Luc Montagnier
This year the Nobel Assembly at Karolinska Institutet has decided to award The Nobel Prize in Medicine to Françoise Barré-Sinoussi and Luc Montagnier for their discovery of "human immunodeficiency virus" (HIV). As director of the scientific council of the ANRS (French National Agency for Research on AIDS and Viral Hepatitis), Françoise Barré-Sinoussi supported MEND’s 2008 conference on vaccine and technology for diseases of poverty. Read more.
3 October, 2008
TED Prize Winner James Nachtwey Unveils XDR-TB Focus of Global Photography Wish Project
The photojournalist James Nachtwey received the TED prize and as a result of this prize he wished to raise public awareness on XDR-TB (extra drug resistant tuberculosis). The photographer as been concerned by this disease for several years and MEND supported his experiment with Dr Anne Goldfeld, a Harvard professor who has been building clinics in Cambodia for the last 20 years. After a year dialogue between the artist and the scientist an exhibition was released capturing the complexities of patients who suffer from AIDS and tuberculosis. The exhibit was presented at Le Laboratoire during MEND conference on vaccine and drug for infectious diseases. Read more. | Watch the Videos.
25 March, 2008
Immunization by a bacterial aerosol, PNAS – proceedings of the National Academy of Sciences of the United States of America
By manufacturing a single-particle system in two particulate forms (i.e., micrometer size and nanometer size), we have designed a bacterial vaccine form that exhibits improved efficacy of immunization. Microstructural properties are adapted to alter dispersive and aerosol properties independently. Read more.
Press Contact
For media inquiries, contact ntassel@medicineinneed.org.